Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1966 1
1970 4
1971 1
1972 3
1973 7
1974 11
1975 9
1976 5
1977 7
1978 7
1979 6
1980 10
1981 10
1982 2
1983 6
1984 4
1985 3
1986 8
1987 7
1988 7
1989 6
1990 10
1991 12
1992 13
1993 12
1994 8
1995 9
1996 13
1997 26
1998 13
1999 22
2000 13
2001 12
2002 15
2003 17
2004 16
2005 20
2006 13
2007 10
2008 15
2009 15
2010 13
2011 12
2012 11
2013 15
2014 8
2015 8
2016 7
2017 3
2018 6
2019 7
2020 5
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

476 results
Results by year
Filters applied: . Clear all
Page 1
The FLAMSA concept-past and future.
Kolb HJ, Schmid C. Kolb HJ, et al. Ann Hematol. 2020 Sep;99(9):1979-1988. doi: 10.1007/s00277-020-04131-1. Epub 2020 Jun 27. Ann Hematol. 2020. PMID: 32594216 Review.
Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants.
Hehlmann R, Lauseker M, Saußele S, Pfirrmann M, Krause S, Kolb HJ, Neubauer A, Hossfeld DK, Nerl C, Gratwohl A, Baerlocher GM, Heim D, Brümmendorf TH, Fabarius A, Haferlach C, Schlegelberger B, Müller MC, Jeromin S, Proetel U, Kohlbrenner K, Voskanyan A, Rinaldetti S, Seifarth W, Spieß B, Balleisen L, Goebeler MC, Hänel M, Ho A, Dengler J, Falge C, Kanz L, Kremers S, Burchert A, Kneba M, Stegelmann F, Köhne CA, Lindemann HW, Waller CF, Pfreundschuh M, Spiekermann K, Berdel WE, Müller L, Edinger M, Mayer J, Beelen DW, Bentz M, Link H, Hertenstein B, Fuchs R, Wernli M, Schlegel F, Schlag R, de Wit M, Trümper L, Hebart H, Hahn M, Thomalla J, Scheid C, Schafhausen P, Verbeek W, Eckart MJ, Gassmann W, Pezzutto A, Schenk M, Brossart P, Geer T, Bildat S, Schäfer E, Hochhaus A, Hasford J. Hehlmann R, et al. Among authors: kolb hj. Leukemia. 2017 Nov;31(11):2398-2406. doi: 10.1038/leu.2017.253. Epub 2017 Aug 14. Leukemia. 2017. PMID: 28804124 Free PMC article. Clinical Trial.
Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open-label, multicentre phase 3 trial.
Finke J, Bethge WA, Schmoor C, Ottinger HD, Stelljes M, Zander AR, Volin L, Ruutu T, Heim DA, Schwerdtfeger R, Kolbe K, Mayer J, Maertens JA, Linkesch W, Holler E, Koza V, Bornhäuser M, Einsele H, Kolb HJ, Bertz H, Egger M, Grishina O, Socié G; ATG-Fresenius Trial Group. Finke J, et al. Among authors: kolb hj. Lancet Oncol. 2009 Sep;10(9):855-64. doi: 10.1016/S1470-2045(09)70225-6. Epub 2009 Aug 18. Lancet Oncol. 2009. PMID: 19695955 Clinical Trial.
Delayed Transfer of Immune Cells or the Art of Donor Lymphocyte Infusion.
Frederik Falkenburg JH, Schmid C, Kolb HJ, Locatelli F, Kuball J. Frederik Falkenburg JH, et al. Among authors: kolb hj. In: Carreras E, Dufour C, Mohty M, Kröger N, editors. The EBMT Handbook: Hematopoietic Stem Cell Transplantation and Cellular Therapies [Internet]. 7th edition. Cham (CH): Springer; 2019. Chapter 59. The EBMT Handbook: Hematopoietic Stem Cell Transplantation and Cellular Therapies. 7th edition. 2019. PMID: 32091816 Free Books & Documents. Review.
Hematopoietic stem cell transplantation and cellular therapy.
Kolb HJ. Kolb HJ. HLA. 2017 May;89(5):267-277. doi: 10.1111/tan.13005. HLA. 2017. PMID: 28371460 Review.
Emerging Role of Mesenchymal Stromal Cell-Derived Extracellular Vesicles in Pathogenesis of Haematological Malignancies.
Cominal JG, da Costa Cacemiro M, Pinto-Simões B, Kolb HJ, Malmegrim KCR, de Castro FA. Cominal JG, et al. Among authors: kolb hj. Stem Cells Int. 2019 Jun 2;2019:6854080. doi: 10.1155/2019/6854080. eCollection 2019. Stem Cells Int. 2019. PMID: 31281380 Free PMC article. Review.
Tolerance and chimerism.
Kolb HJ, Guenther W, Gyurkocza B, Hoetzl F, Simoes B, Falk C, Schleuning M, Ledderose G. Kolb HJ, et al. Transplantation. 2003 May 15;75(9 Suppl):26S-31S. doi: 10.1097/01.TP.0000067948.90241.82. Transplantation. 2003. PMID: 12819487 Review.
Prevention and treatment of relapse after stem cell transplantation by cellular therapies.
Falkenburg F, Ruggiero E, Bonini C, Porter D, Miller J, Malard F, Mohty M, Kröger N, Kolb HJ. Falkenburg F, et al. Among authors: kolb hj. Bone Marrow Transplant. 2019 Jan;54(1):26-34. doi: 10.1038/s41409-018-0227-0. Epub 2018 May 24. Bone Marrow Transplant. 2019. PMID: 29795426 Review.
Donor lymphocyte infusions.
Giralt SA, Kolb HJ. Giralt SA, et al. Among authors: kolb hj. Curr Opin Oncol. 1996 Mar;8(2):96-102. doi: 10.1097/00001622-199603000-00004. Curr Opin Oncol. 1996. PMID: 8727301 Review.
Serum Chemokine-release Profiles in AML-patients Might Contribute to Predict the Clinical Course of the Disease.
Merle M, Fischbacher D, Liepert A, Grabrucker C, Kroell T, Kremser A, Dreyssig J, Freudenreich M, Schuster F, Borkhardt A, Kraemer D, Koehne CH, Kolb HJ, Schmid C, Schmetzer HM. Merle M, et al. Among authors: kolb hj. Immunol Invest. 2020 May;49(4):365-385. doi: 10.1080/08820139.2019.1661429. Epub 2019 Sep 19. Immunol Invest. 2020. PMID: 31535582
476 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback